Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90285342 | 9028534 | 2 | F | 20160830 | 20130124 | 20160906 | EXP | RU-ROCHE-1182138 | ROCHE | , KRAVCHENKO S, GEMDZHIAN E, MANGASAROVA J, BARYAKH E, KOVRIGINA A, OBUKHOVA T, KAPLANOV K AND DUBROVIN E, LESS TOXIC GEMCITABINE-OXALIPLATIN BASED INDUCTION REGIMEN (R-GIDIOX) PRIOR TO AUTOLOGOUS SCT PRODUCES OUTCOMES SIMILAR TO HIGH-DOSE CYTARABINE CONTAINING INTENSIVE INDUCTION REGIMEN IN MANTLE CELL LYMPHOMA - A FOLLOW UP REPORT OF THE [..]. BLOOD 2014;124(21):-. | 0.00 | Y | 0.00000 | 20160906 | MD | RU | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90285342 | 9028534 | 1 | PS | Rituximab | RITUXIMAB | 1 | Unknown | 375 MG/M SUP 2 DAY 0 | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 90285342 | 9028534 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | 800 MG/M SUP 2 DAYS 1 AND 4 | U | 0 | |||||||||
| 90285342 | 9028534 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 120 MG/M SUP 2 DAY 2 | U | 0 | |||||||||
| 90285342 | 9028534 | 4 | SS | IRINOTECAN HYDROCHLORIDE. | IRINOTECAN HYDROCHLORIDE | 1 | Unknown | 100 MG/M SUP 2 DAY 3 | U | 0 | |||||||||
| 90285342 | 9028534 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 10 MG/M SUP 2 IV DAYS 1-5 | U | 0 | |||||||||
| 90285342 | 9028534 | 6 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 1000 MG/M SUP 2 DAYS 1-5 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90285342 | 9028534 | 1 | Mantle cell lymphoma |
| 90285342 | 9028534 | 2 | Mantle cell lymphoma |
| 90285342 | 9028534 | 3 | Mantle cell lymphoma |
| 90285342 | 9028534 | 4 | Mantle cell lymphoma |
| 90285342 | 9028534 | 5 | Mantle cell lymphoma |
| 90285342 | 9028534 | 6 | Mantle cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 90285342 | 9028534 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90285342 | 9028534 | Leukopenia | |
| 90285342 | 9028534 | Thrombocytopenia | |
| 90285342 | 9028534 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |